Highlights
- 1
- 2Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021
- 3Clinical cancer research : an official journal of the American Association for Cancer Research · 2020
Publications
317 publications
Funding
12 grantsView NIH portfolio on RePORTER ↗
Active
7 grants- MPIBridging Gaps and Transforming CARE for Young Breast Cancer Survivors and those with Metastatic DiseaseCenters for Disease Control and Prevention · 2024–2029No publications yetNU58DP007916-03-00
- PIDietary and Pharmacologic Interventions to Optimize Weight in Individuals with Breast CancerBreast Cancer Research Foundation · 2026–2028BCRF-26-154
- Sub-PICardiac risks after contemporary radiation for breast cancer on prospective radiotherapy trialsBreast Cancer Research Foundation · 2026–2027 · via NRG OncologyCONS-26-010
- Co-IHarnessing Innate Immunity and Radiotherapy for Next-Generation Immuno-Oncology in Metastatic Breast CancerMETAvivor Research and Support, Inc. · 2025–2027MRS 243992-01
- MPINRG Oncology Network Group Operations CenterNational Cancer Institute · 2023–2027 · via NRG Oncology· 2 renewalsU10CA180868-12
- PICorrelative biomarkers to optimize breast cancer treatment and prevention strategiesBreast Cancer Research Foundation · 2024–2026BCRF-24-154
- Sub-PICardiac risks after contemporary radiation for breast cancer on prospective radiotherapy trialsBreast Cancer Research Foundation · 2024–2026 · via NRG OncologyCONS-24-010
Completed grants (5)
- PINew Approaches to Breast Cancer PreventionBreast Cancer Research Foundation · 2023–2024BCRF-23-154
- Sub-PIBreast Cancer in Young Women-Thriving After a DiagnosisCenters for Disease Control and Prevention · 2023–2024 · via The Johns Hopkins UniversityNo publications yetNU58DP006673-05-00
- PIYOUNG WOMEN WITH BREAST CANCER PROGRAM AT JOHNS HOPKINS: SURVIVING AND THRIVINGNIH · 2014–2019 · via NIH RePORTERNo publications yetU58DP005410-01
- PITHE EFFECTS OF 24 MONTHS OF EXEMESTANE OR LETROZOLE ON SURROGATE MARKERSNCRR · 2006–2007 · via NIH RePORTERM01RR000052-46
Clinical research
1 study
Active
1 study- PINCT05879926A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)PHASE3 · NRG Oncology · OPEN TO ACCRUAL (as of 2024)Breast Cancer
News mentions
1 mentionView all WCM news ↗
- CDC Grant Funds Initiatives for Breast Cancer PatientsJanuary 6, 2025
The five-year, $2.3 million grant from the Centers for Disease Control and Prevention will seek to improve equitable access to care, quality of life and survival outcomes for young people with all stages of breast cancer.
External relationships
Advisory/Scientific Board Member
Astellas Pharma Global Development, Inc.
Professional Services
AstraZeneca Pharmaceuticals LP · The Johns Hopkins University